Language Select
Logo Varian

Actualités récentes

Août 21, 2019
Varian (NYSE: VAR) today announced that Phil Febbo, MD, chief medical officer (CMO) at Illumina has been appointed to the Varian Board of Directors, effective August 16, 2019. "We are proud to... Read more
Août 21, 2019
Varian (NYSE: VAR) today announced it has successfully completed its asset purchase of the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating... Read more
Août 19, 2019
Varian (NYSE: VAR) today announced that its executive management team will be hosting an Investor Day on Friday, November 15, 2019 at The Plaza Hotel, Fifth Avenue at Central Park South, New York,... Read more

Dernières publications du blog

Août 20, 2019 | Centerline
Varian introduced the Bravos afterloader system at ASTRO in 2018, in response to a growing need for an easy-to-use, efficient system. In this article, the clinical team at the UK-based Norfolk and... Read more
Juil. 08, 2019 | Centerline
Since its introduction in 2017, Varian’s HyperArc™ high-definition radiotherapy has been deployed to deliver noncoplanar stereotactic radiosurgery (SRS) at sites around the world. Physicists in the... Read more
Juin 27, 2019 | Centerline
After 20 years with one oncology information system (OIS), migrating to a new one is a serious step, but it’s one that Baton Rouge General took in the summer of 2016 with an eye to the future for its... Read more

Recevez les actualités par e-mail
Abonnez-vous maintenant

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com